相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。p40 (ΔNp63) is more specific than p63 and cytokeratin 5 in identifying squamous cell carcinoma of bronchopulmonary origin: A review and comparative analysis
Adam P. Vogt et al.
DIAGNOSTIC CYTOPATHOLOGY (2014)
p40: A p63 Isoform Useful for Lung Cancer Diagnosis - A Review of the Physiological and Pathological Role of p63
Ana Rita Nobre et al.
ACTA CYTOLOGICA (2013)
p40 (ΔNp63) and keratin 34βE12 provide greater diagnostic accuracy than p63 in the evaluation of small cell lung carcinoma in small biopsy samples
Kelly J. Butnor et al.
HUMAN PATHOLOGY (2013)
Subtyping Non-Small Cell Lung Cancer: Relevant Issues and Operative Recommendations for the Best Pathology Practice
Giulio Rossi et al.
INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY (2013)
Napsin A, a New Marker for Lung Adenocarcinoma, Is Complementary and More Sensitive and Specific Than Thyroid Transcription Factor 1 in the Differential Diagnosis of Primary Pulmonary Carcinoma Evaluation of 1674 Cases by Tissue Microarray
Bradley M. Turner et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2012)
Evaluation of Napsin A, Cytokeratin 5/6, p63, and Thyroid Transcription Factor 1 in Adenocarcinoma Versus Squamous Cell Carcinoma of the Lung
Kenneth Whithaus et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2012)
Large-scale comparative analyses of immunomarkers for diagnostic subtyping of non-small-cell lung cancer biopsies
Arne Warth et al.
HISTOPATHOLOGY (2012)
ΔNp63 (p40) and Thyroid Transcription Factor-1 Immunoreactivity on Small Biopsies or Cellblocks for Typing Non-small Cell Lung Cancer A Novel Two-Hit, Sparing-Material Approach
Giuseppe Pelosi et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
p40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma
Justin A. Bishop et al.
MODERN PATHOLOGY (2012)
Cyto-histologic agreement in pathologic subtyping of non small cell lung carcinoma: Review of 602 fine needle aspirates with follow-up surgical specimens over a nine year period and analysis of factors underlying failure to subtype
Gilda da Cunha Santos et al.
LUNG CANCER (2012)
Subclassification of Non-small Cell Lung Carcinomas Lacking Morphologic Differentiation on Biopsy Specimens: Utility of an Immunohistochemical Panel Containing TTF-1, Napsin A, p63, and CK5/6
Sanjay Mukhopadhyay et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
Immunohistochemical Subtyping of Nonsmall Cell Lung Cancer Not Otherwise Specified in Fine-Needle Aspiration Cytology A Retrospective Study of 103 Cases With Surgical Correlation
Luisella Righi et al.
CANCER (2011)
Immunhistochemistry by Means of Widely Agreed-Upon Markers (Cytokeratins 5/6 and 7, p63, Thyroid Transcription Factor-1, and Vimentin) on Small Biopsies of Non-small Cell Lung Cancer Effectively Parallels the Corresponding Profiling and Eventual Diagnoses on Surgical Specimens
Giuseppe Pelosi et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
William D. Travis et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens
Natasha Rekhtman et al.
MODERN PATHOLOGY (2011)
Optimal Immunohistochemical Markers For Distinguishing Lung Adenocarcinomas From Squamous Cell Carcinomas in Small Tumor Samples
Jefferson Terry et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2010)
Subtyping of Undifferentiated Non-small Cell Carcinomas in Bronchial Biopsy Specimens
Peh Sun Loo et al.
JOURNAL OF THORACIC ONCOLOGY (2010)
Refining the Diagnosis and EGFR Status of Non-small Cell Lung Carcinoma in Biopsy and Cytologic Material, Using a Panel of Mucin Staining, TTF-1, Cytokeratin 5/6, and P63, and EGFR Mutation Analysis
Andrew G. Nicholson et al.
JOURNAL OF THORACIC ONCOLOGY (2010)
Clinical Features and Outcome of Patients With Non-Small-Cell Lung Cancer Who Harbor EML4-ALK
Alice T. Shaw et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer
Christopher G. Azzoli et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
The Differential Efficacy of Pemetrexed According to NSCLC Histology: A Review of Two Phase III Studies
Giorgio Scagliotti et al.
ONCOLOGIST (2009)
Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer
Giorgio Vittorio Scagliotti et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer
Alan Sandler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Erlotinib in previously treated non-small-cell lung cancer
FA Shepherd et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Phase I/II trial evaluating the anti-vascular endothelial growth factor monoclonal antibody bevacizumab in combination with the HER-1/epidermal growth factor receptor tyrosine kinase inhibitor erlotinib for patients with recurrent non-small-cell lung cancer
RS Herbst et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
p63 expression in lung carcinoma - A tissue microarray study of 408 cases
NHC Au et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2004)
EGFR mutations in lung cancer:: Correlation with clinical response to gefitinib therapy
JG Paez et al.
SCIENCE (2004)
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
TJ Lynch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
A comparative study of machine-learning methods to predict the effects of single nucleotide polymorphisms on protein function
VG Krishnan et al.
BIOINFORMATICS (2003)
p63 in pulmonary epithelium, pulmonary squamous neoplasms, and other pulmonary tumors
BY Wang et al.
HUMAN PATHOLOGY (2002)
p63 immunoreactivity in lung cancer: yet another player in the development of squamous cell carcinomas?
G Pelosi et al.
JOURNAL OF PATHOLOGY (2002)
Preoperative histological classification of primary lung cancer: accuracy of diagnosis and use of the non-small cell category
SL Edwards et al.
JOURNAL OF CLINICAL PATHOLOGY (2000)
分享论文
